Beyond Emergencies: Why Canada Needs a Long-Term Pharmaceutical Manufacturing Strategy
- CPMEA
- Jun 11
- 2 min read
June 11, 2026, Toronto - As global trade tensions rise and countries around the world rethink critical supply chains, Canada faces an important question: what role should domestic pharmaceutical manufacturing play in our long-term national strategy?
Too often, discussions about pharmaceutical production only gain attention during moments of crisis. During the COVID-19 pandemic, Canadians saw firsthand how fragile global healthcare supply chains can become under pressure. But the conversation about domestic manufacturing should not begin and end with emergencies.
The reality is that pharmaceutical manufacturing is part of the infrastructure that supports a modern, resilient country. Like energy, transportation, and telecommunications, access to medicines depends on stable systems, strategic planning, and long-term investment.
Canada Has a Strong Foundation to Build Upon
Canada already has a strong foundation. Domestic pharmaceutical manufacturers operate facilities across the country, employ highly skilled workers, and produce many of the medicines Canadians rely on every day. Canadian manufacturers also contribute to broader economic activity through production, packaging, warehousing, distribution, and supply chain operations.
Generic and contract pharmaceutical manufacturers play a particularly important role in supporting Canada’s healthcare system and economy. Generic medicines account for the majority of prescriptions dispensed in Canada and are an essential part of everyday healthcare delivery across the country.
Maintaining this domestic capacity is critical not only for healthcare resilience, but also for economic stability and long-term competitiveness.
Global Competition Is Accelerating
Governments in the United States, Europe, and elsewhere are introducing aggressive policies designed to strengthen domestic pharmaceutical production. These include procurement preferences, investment incentives, tax measures, and streamlined regulatory pathways aimed at attracting and retaining manufacturing capacity.
Countries increasingly recognize that pharmaceutical manufacturing is tied not only to healthcare, but also to economic resilience, trade security, and national preparedness.
Canada cannot afford to take a passive approach while other jurisdictions move aggressively to secure investment and expand domestic production capabilities.
A Balanced and Strategic Approach
A long-term strategy for pharmaceutical manufacturing should focus on creating stable conditions that allow domestic manufacturers to remain competitive and continue investing in Canadian operations. That includes policies that support domestic production, efficient regulatory systems, competitive market conditions, and coordinated collaboration between industry and government.
Importantly, this is not about isolationism or disengaging from global trade. Canada benefits from strong international partnerships and integrated North American supply chains. But recent geopolitical uncertainty has reinforced the importance of balance. A resilient system requires both trusted international partnerships and sufficient domestic capacity.
Looking Ahead
The question is no longer whether pharmaceutical manufacturing matters strategically. The question is whether Canada is prepared to take the steps necessary to support and sustain it for the future.
The Canadian Pharmaceutical Manufacturers and Exporters Alliance (CPMEA) continues to advocate for policies that strengthen domestic pharmaceutical manufacturing and support a more resilient healthcare system for Canadians.
Learn more at www.cpmea.ca.
The Canadian Pharmaceutical Manufacturers and Exporters Alliance (CPMEA) – Alliance fabricants et exportateurs pharmaceutiques du Canada (AFEPC) represents pharmaceutical companies that manufacture in Canada. We have come together in an Alliance to tell the story of drug production in Canada and to raise awareness of the unique issues facing our industry.
Click here to contact us, or email us directly at info@cpmea.ca.
